- Investing Ideas
- South Korean Pharmaceuticals & Biotech Sustainable Track Record
South Korean Pharmaceuticals & Biotech Sustainable Track Record
Results
6
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
6 companies
PharmaResearch
Market Cap: ₩3.9t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩378,000.00
7D
-3.3%
1Y
-36.8%
Samsung BiologicsLtd
Market Cap: ₩69.0t
Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,491,000.00
7D
0.8%
1Y
-5.9%
Oscotec
Market Cap: ₩1.3t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩33,600.00
7D
15.3%
1Y
6.5%
JW Shinyak
Market Cap: ₩112.0b
Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
A067290
₩2,005.00
7D
28.0%
1Y
32.4%
JW Holdings
Market Cap: ₩263.6b
Operates as a healthcare company in South Korea, the United States, Japan, China, and internationally.
A096760
₩3,810.00
7D
6.1%
1Y
8.9%
SK Biopharmaceuticals
Market Cap: ₩6.4t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩82,000.00
7D
8.5%
1Y
-19.2%